| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.035 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.036 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.035 | 0.9 |